Twinbeech Capital LP Invitae Corp Transaction History

Twinbeech Capital LP

  • $4.99 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.13 - $9.01 $33,308 - $140,898
-15,638 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$6.28 - $15.59 $98,206 - $243,796
15,638 New
15,638 $125,000
Q3 2021

Nov 15, 2021
SELL
$24.31 - $33.6 $1.4 Million - $1.94 Million
-57,729 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$26.09 - $40.4 $1.51 Million - $2.33 Million
57,729 New
57,729 $1.95 Million

Others Institutions Holding NVTA

# of Institutions
20
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email